Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.70
-0.70 (-1.24%)
May 12, 2026, 9:47 AM EDT - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $150.52 million as of May 12, 2026. Its market cap has increased by 2,645.84% in one year.
Market Cap
150.52M
Enterprise Value
104.24M
1-Year Change
2,645.84%
Ranking
Category
Stock Price
$55.70
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $150.52M, a decrease of -60.23%. That is a compound annual growth rate of -15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 152.41M | 63.46% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 165.00M |
| AN2 Therapeutics | 160.54M |
| Immunic | 158.17M |
| OnKure Therapeutics | 157.95M |
| Jyong Biotech | 157.65M |
| Protalix BioTherapeutics | 156.31M |
| Molecular Partners AG | 155.41M |
| TuHURA Biosciences | 151.32M |